DAM
Deltec Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.9M | Buy |
2,794,892
+78,519
| +3% | +$729K | 4.62% | 5 |
|
2025
Q1 | $19.9M | Buy |
2,716,373
+100,000
| +4% | +$733K | 4.28% | 4 |
|
2024
Q4 | $22.3M | Buy |
2,616,373
+16,300
| +0.6% | +$139K | 4.42% | 5 |
|
2024
Q3 | $22.6M | Buy |
2,600,073
+9,808
| +0.4% | +$85.3K | 4.46% | 5 |
|
2024
Q2 | $17.7M | Buy |
2,590,265
+226,181
| +10% | +$1.55M | 3.39% | 6 |
|
2024
Q1 | $21.5M | Sell |
2,364,084
-79,523
| -3% | -$724K | 4.24% | 5 |
|
2023
Q4 | $10.9M | Buy |
2,443,607
+381,810
| +19% | +$1.7M | 2.45% | 10 |
|
2023
Q3 | $6.47M | Buy |
2,061,797
+87,000
| +4% | +$273K | 1.47% | 16 |
|
2023
Q2 | $10.2M | Buy |
1,974,797
+61,185
| +3% | +$316K | 2.23% | 12 |
|
2023
Q1 | $10.1M | Buy |
1,913,612
+60,667
| +3% | +$320K | 2.49% | 10 |
|
2022
Q4 | $5.21M | Sell |
1,852,945
-470,728
| -20% | -$1.32M | 1.49% | 16 |
|
2022
Q3 | $9.64M | Buy |
2,323,673
+254,360
| +12% | +$1.06M | 2.37% | 7 |
|
2022
Q2 | $8.32M | Sell |
2,069,313
-7,000
| -0.3% | -$28.1K | 1.95% | 11 |
|
2022
Q1 | $10.3M | Sell |
2,076,313
-19,000
| -0.9% | -$94.1K | 1.76% | 13 |
|
2021
Q4 | $14.6M | Sell |
2,095,313
-54,000
| -3% | -$376K | 2.38% | 8 |
|
2021
Q3 | $21.5M | Sell |
2,149,313
-18,000
| -0.8% | -$180K | 3.24% | 5 |
|
2021
Q2 | $30.7M | Buy |
2,167,313
+70,972
| +3% | +$1.01M | 4.23% | 4 |
|
2021
Q1 | $34.4M | Sell |
2,096,341
-72,232
| -3% | -$1.19M | 5.13% | 3 |
|
2020
Q4 | $44.9M | Sell |
2,168,573
-303,494
| -12% | -$6.28M | 6.87% | 1 |
|
2020
Q3 | $18.8M | Buy |
2,472,067
+141,800
| +6% | +$1.08M | 3.36% | 6 |
|
2020
Q2 | $19.4M | Buy |
2,330,267
+256,548
| +12% | +$2.14M | 4.06% | 4 |
|
2020
Q1 | $10.3M | Sell |
2,073,719
-49,339
| -2% | -$244K | 2.84% | 9 |
|
2019
Q4 | $8.39M | Buy |
2,123,058
+114,574
| +6% | +$453K | 1.7% | 16 |
|
2019
Q3 | $6.11M | Buy |
2,008,484
+592,237
| +42% | +$1.8M | 1.53% | 15 |
|
2019
Q2 | $6.23M | Buy |
1,416,247
+591,500
| +72% | +$2.6M | 1.36% | 19 |
|
2019
Q1 | $3.27M | Buy |
824,747
+100,000
| +14% | +$397K | 0.72% | 36 |
|
2018
Q4 | $2.89M | Buy |
724,747
+104,802
| +17% | +$417K | 0.8% | 33 |
|
2018
Q3 | $4.27M | Buy |
619,945
+86,959
| +16% | +$598K | 0.82% | 37 |
|
2018
Q2 | $3.6M | Sell |
532,986
-53,253
| -9% | -$359K | 0.73% | 41 |
|
2018
Q1 | $3.82M | Buy |
586,239
+372,000
| +174% | +$2.42M | 0.76% | 43 |
|
2017
Q4 | $953K | Sell |
214,239
-95,468
| -31% | -$425K | 0.19% | 95 |
|
2017
Q3 | $1.91M | Sell |
309,707
-42,143
| -12% | -$260K | 0.39% | 65 |
|
2017
Q2 | $3.26M | Sell |
351,850
-47,350
| -12% | -$438K | 0.67% | 57 |
|
2017
Q1 | $3.71M | Buy |
399,200
+284,200
| +247% | +$2.64M | 0.76% | 47 |
|
2016
Q4 | $963K | Buy |
+115,000
| New | +$963K | 0.23% | 96 |
|